Refractory Bullous Pemphigoid Improved by Discontinuation of Phenytoin as an CYP3A4 Inducer. [electronic resource]
Producer: 20210315Description: adv00108 p. digitalISSN:- 1651-2057
- Aged
- Anti-Inflammatory Agents -- therapeutic use
- Anticonvulsants -- therapeutic use
- Cerebral Palsy -- complications
- Cytochrome P-450 CYP3A Inducers -- therapeutic use
- Drug Substitution
- Epilepsy -- complications
- Humans
- Levetiracetam -- therapeutic use
- Male
- Pemphigoid, Bullous -- complications
- Phenytoin -- therapeutic use
- Prednisolone -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.